Tamara Rothenburger

Frankfurt Am Main, HE, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Discovery of synthetic G-quadruplex DNA as SARS-CoV-2 helicase inhibitor with antiviral, anti-inflammatory and antioxidative properties.

Discovery of synthetic G-quadruplex DNA as SARS-CoV-2 helicase inhibitor with antiviral, anti-inflammatory and antioxidative properties.

Journal: Cell death discovery

Published: November 20, 2025

Papaverine Targets STAT Signaling: A Dual-Action Therapy Option Against SARS-CoV-2.

Papaverine Targets STAT Signaling: A Dual-Action Therapy Option Against SARS-CoV-2.

Journal: Journal of medical virology

Published: November 16, 2024

Repurposing of the antibiotic nitroxoline for the treatment of mpox.

Repurposing of the antibiotic nitroxoline for the treatment of mpox.

Journal: Journal of medical virology

Published: January 25, 2023

Drug Sensitivity of Currently Circulating Mpox Viruses.

Drug Sensitivity of Currently Circulating Mpox Viruses.

Journal: The New England journal of medicine

Published: December 28, 2022

Omicron-induced interferon signaling prevents influenza A H1N1 and H5N1 virus infection.

Omicron-induced interferon signaling prevents influenza A H1N1 and H5N1 virus infection.

Journal: Journal of medical virology

Published: September 26, 2022

Identification of novel antiviral drug candidates using an optimized SARS-CoV-2 phenotypic screening platform.

Identification of novel antiviral drug candidates using an optimized SARS-CoV-2 phenotypic screening platform.

Journal: iScience

Published: September 12, 2022

Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants.

Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants.

Journal: The Journal of infection

Published: July 26, 2022

SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment.

SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment.

Journal: Cell discovery

Published: January 26, 2022

Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells.

Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells.

Journal: Journal of experimental & clinical cancer research : CR

Published: August 06, 2021

SAMHD1 is a key regulator of the lineage-specific response of acute lymphoblastic leukaemias to nelarabine.

SAMHD1 is a key regulator of the lineage-specific response of acute lymphoblastic leukaemias to nelarabine.

Journal: Communications biology

Published: December 31, 2019

Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AML.

Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AML.

Journal: Nature communications

Published: August 14, 2018

Showing 1-11 of 11

Last Updated: 09/26/2026